89bio, Inc. (ETNB) is currently Overvalued by 1655.67%

Instant valuation answer

89bio, Inc. (ETNB) appears overvalued by approximately 1655.67% based on our live valuation percent and intrinsic value estimate derived from DCF, P/E Multiple, and P/S Multiple models. Valuation can still differ across analyst models, growth expectations, and risk assumptions.

  • Downside (live) 1655.67% (from live valuation API)
  • Confidence (live) 8.5/10 (High conviction overvalued)

Confidence Score is based on the magnitude of upside or downside vs intrinsic value.

Fair value estimate

Unlock fair value

Current price

$14.84

Stock valuation checker

Search our company database (same as the site header). Choose a result or type a ticker and press Check valuation.

Explore Our Valuation Calculators

Why is 89bio, Inc. overvalued or undervalued?

Intrinsic value work anchors 89bio, Inc. on owner earnings and balance-sheet capacity; the current quote trades above that anchor, which frames the stock as relatively rich on a fundamentals-first view.

Versus historical valuation bands, ETNB is closer to the upper end of where this business has traded when profitability and growth were comparable—useful context before reading any single headline multiple.

Forward market expectations are elevated: the price requires heroic assumptions to converge with our fair-value zone, but sector peers and macro rates still deserve a quick sanity check on the company page.

Key metrics

P/E ratio
27.3x
Revenue growth (TTM y/y)
14%
Profit margin
34.0%
Fair value (model)
Unlock

Frequently asked questions — ETNB

Is ETNB overvalued right now?

Based on our 2026 models, 89bio, Inc. (ETNB) appears overvalued at $14.84 with roughly 1655.7% downside versus fair value. Confirm with valuation ratios and financials before acting.

What is 89bio, Inc.'s intrinsic value?

Our DCF, P/E Multiple, and P/S Multiple models estimate whether ETNB trades above or below fair value. At $14.84, 89bio, Inc. currently looks overvalued on this snapshot. Tickerplace Pro unlocks the full dollar fair value estimate.

How is 89bio, Inc.'s intrinsic value calculated?

Tickerplace calculates ETNB's fair value using Discounted Cash Flow (DCF), P/E Multiple, and P/S Multiple models. We compare the resulting intrinsic value estimate to the live market price to flag undervalued or overvalued positioning.

Is ETNB undervalued right now?

A stock is undervalued when price sits below a supportable fair value range. Check whether ETNB's gap aligns with fundamentals using the ratios and financial links on this page.

Peers for ETNB: open their overvalued / undervalued view.